Liu Y - Search Results

1

ERBB4 acts as a suppressor in the development of hepatocellular carcinoma.

Liu Y, Song L, Ni H, Sun L, Jiao W, Chen L, Zhou Q, Shen T, Cui H, Gao T, Li J. Liu Y, et al. Carcinogenesis. 2017 Apr 1;38(4):465-473. doi: 10.1093/carcin/bgx017. Carcinogenesis. 2017. PMID: 28334319

2

Genetic variants in ERBB4 is associated with chronic hepatitis B virus infection.

Liu Y, Zhou Q, He XS, Song LM, Chen L, Jiao WJ, Shen T, Yao S, Wu H, Hu ZB, Gao TM, Li JM. Liu Y, et al. Oncotarget. 2016 Jan 26;7(4):4981-92. doi: 10.18632/oncotarget.6650. Oncotarget. 2016. PMID: 26701850 Free PMC article.

3

ErbB4 acts as a suppressor in colitis and its associated carcinoma by negatively regulating cholesterol metabolism.

Ni H, Chen L, Song L, Sun L, Cui H, Zhou Q, Hu C, Jiao W, Shen T, Gao T, Liu Y, Li J. Ni H, et al. Among authors: liu y. Carcinogenesis. 2019 Jul 4;40(5):680-686. doi: 10.1093/carcin/bgy164. Carcinogenesis. 2019. PMID: 30452622

4

Corrigendum: ErbB4 acts as a suppressor in colitis and its associated carcinoma by negatively regulating cholesterol metabolism.

Ni H, Chen L, Song L, Sun L, Cui H, Zhou Q, Hu C, Jiao W, Shen T, Gao T, Liu Y, Li J. Ni H, et al. Among authors: liu y. Carcinogenesis. 2019 Aug 22;40(8):1053-1054. doi: 10.1093/carcin/bgz063. Carcinogenesis. 2019. PMID: 31329825 No abstract available.

5

Different miR-21-3p isoforms and their different features in colorectal cancer.

Jiao W, Leng X, Zhou Q, Wu Y, Sun L, Tan Y, Ni H, Dong X, Shen T, Liu Y, Li J. Jiao W, et al. Among authors: liu y. Int J Cancer. 2017 Nov 15;141(10):2103-2111. doi: 10.1002/ijc.30902. Epub 2017 Aug 2. Int J Cancer. 2017. PMID: 28734015

6

Higher variety and quantity of microRNA-139-5p isoforms confer suppressive role in hepatocellular carcinoma.

Ni H, Dai X, Leng X, Deng M, Qin Y, Ji Q, Xu C, Li J, Liu Y. Ni H, et al. Among authors: liu y. J Cell Biochem. 2018 Aug;119(8):6806-6813. doi: 10.1002/jcb.26874. Epub 2018 Apr 25. J Cell Biochem. 2018. PMID: 29693285

7

Dicer deletion in hepatocytes promotes macrophages M1 polarization through dysregulated miR-192-3p/IGF2 in non-alcoholic steatohepatitis and hepatocellular carcinoma.

Hu C, Li X, Sui Y, Chen Y, Zhao Y, Yang Y, Zhou Q, Ni H, Sun L, Gan W, Li J, Liu Y. Hu C, et al. Among authors: liu y. Cancer Gene Ther. 2022 Aug;29(8-9):1252-1262. doi: 10.1038/s41417-022-00432-x. Epub 2022 Feb 14. Cancer Gene Ther. 2022. PMID: 35165388

8

SIRT1 suppresses colorectal cancer metastasis by transcriptional repression of miR-15b-5p.

Sun LN, Zhi Z, Chen LY, Zhou Q, Li XM, Gan WJ, Chen S, Yang M, Liu Y, Shen T, Xu Y, Li JM. Sun LN, et al. Among authors: liu y. Cancer Lett. 2017 Nov 28;409:104-115. doi: 10.1016/j.canlet.2017.09.001. Epub 2017 Sep 18. Cancer Lett. 2017. PMID: 28923398

9

UBE2L3, a susceptibility gene that plays oncogenic role in hepatitis B-related hepatocellular carcinoma.

Liu Y, Song C, Ni H, Jiao W, Gan W, Dong X, Liu J, Zhu L, Zhai X, Hu Z, Li J. Liu Y, et al. Among authors: liu j. J Viral Hepat. 2018 Nov;25(11):1363-1371. doi: 10.1111/jvh.12963. Epub 2018 Jul 18. J Viral Hepat. 2018. PMID: 29969176

10

NSD2 circular RNA promotes metastasis of colorectal cancer by targeting miR-199b-5p-mediated DDR1 and JAG1 signalling.

Chen LY, Zhi Z, Wang L, Zhao YY, Deng M, Liu YH, Qin Y, Tian MM, Liu Y, Shen T, Sun LN, Li JM. Chen LY, et al. Among authors: liu y, liu yh. J Pathol. 2019 May;248(1):103-115. doi: 10.1002/path.5238. Epub 2019 Feb 20. J Pathol. 2019. PMID: 30666650

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

209,569 results

Search Page

Filters